Published in Retina on December 01, 2014
Endophthalmitis: state of the art. Clin Ophthalmol (2015) 0.98
Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review. Int J Retina Vitreous (2015) 0.82
Immediate Sequential Bilateral Cataract Surgery: A Systematic Review and Meta-Analysis. J Ophthalmol (2015) 0.80
Antibiotic prophylaxis: different practice patterns within and outside the United States. Clin Ophthalmol (2016) 0.78
Antibioprophylaxis in Prevention of Endophthalmitis in Intravitreal Injection: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.76
Survey of intravitreal injection techniques among retina specialists in Israel. Clin Ophthalmol (2016) 0.75
How to prevent endophthalmitis after intravitreal injections. Int J Retina Vitreous (2015) 0.75
Effect of prophylactic timolol 0.1% gel on intraocular pressure after an intravitreal injection of ranibizumab: a randomized study. Clin Ophthalmol (2016) 0.75
The short-needle intravitreal injection technique. Int J Ophthalmol (2016) 0.75
Comment on bilateral same-session intravitreal injections. Int J Ophthalmol (2015) 0.75
Selected Antimicrobial Activity of Topical Ophthalmic Anesthetics. Transl Vis Sci Technol (2016) 0.75
Comparative cyto-histological study of needle tip aspirates and entry sites after intravitreal injection using different needle types. PLoS One (2017) 0.75
Pegaptanib for neovascular age-related macular degeneration. N Engl J Med (2004) 12.01
Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med (2012) 8.83
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol (2007) 8.12
Age-related macular degeneration. N Engl J Med (2008) 7.49
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology (2010) 7.30
A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol (2009) 5.41
Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology (2011) 4.96
Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol (2003) 4.78
Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology (2011) 4.61
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A (2010) 4.30
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov (2006) 4.03
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
Idiopathic macular telangiectasia. Arch Ophthalmol (2006) 3.51
Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina (2006) 3.48
Endophthalmitis associated with intravitreal injections: office-based setting and operating room setting. Retina (2014) 3.41
Evolving guidelines for intravitreous injections. Retina (2004) 3.39
Risks of intravitreous injection: a comprehensive review. Retina (2004) 3.39
Corticosteroids and central serous chorioretinopathy. Ophthalmology (2002) 3.37
Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina (2006) 3.29
Extreme choroidal thinning in high myopia. Retina (2015) 3.23
Childhood uveitis-young patients, old problems, new perspectives. J AAPOS (2008) 3.12
Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol (2004) 2.98
Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center. Retina (2011) 2.97
Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases. Am J Ophthalmol (2013) 2.90
A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study. Am J Ophthalmol (2011) 2.88
Comparison of retrobulbar and sub-Tenon's capsule injection of local anesthetic in vitreoretinal surgery. Ophthalmology (2005) 2.79
Glaucomatous damage of the macula. Prog Retin Eye Res (2012) 2.70
Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol (2005) 2.66
Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology (2003) 2.61
The African Descent and Glaucoma Evaluation Study (ADAGES): design and baseline data. Arch Ophthalmol (2009) 2.59
Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther (2008) 2.59
Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol (2007) 2.53
Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Ophthalmology (2002) 2.51
Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am J Ophthalmol (2006) 2.50
The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol (2002) 2.50
Oct-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysis. Retina (2013) 2.49
Pachychoroid neovasculopathy. Retina (2015) 2.44
Retracted Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization. Retina (2004) 2.43
Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals. Ophthalmology (2005) 2.43
Infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes. Ophthalmology (2012) 2.41
Polypoidal choroidal vasculopathy: a review. Surv Ophthalmol (2010) 2.37
Association between rates of binocular visual field loss and vision-related quality of life in patients with glaucoma. JAMA Ophthalmol (2013) 2.37
Evaluation and management of herpes zoster ophthalmicus. Am Fam Physician (2002) 2.34
Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet (2004) 2.30
Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study. Am J Ophthalmol (2012) 2.30
Epiretinal proliferation seen in association with lamellar macular holes: a distinct clinical entity. Retina (2014) 2.27
Intraocular cysticercosis: case series and comprehensive review of the literature. Ocul Immunol Inflamm (2011) 2.24
Outer retinal tubulation: a novel optical coherence tomography finding. Arch Ophthalmol (2009) 2.22
Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. Ophthalmology (2004) 2.19
Blood vessel contributions to retinal nerve fiber layer thickness profiles measured with optical coherence tomography. J Glaucoma (2008) 2.19
Measurement of local retinal ganglion cell layer thickness in patients with glaucoma using frequency-domain optical coherence tomography. Arch Ophthalmol (2009) 2.18
Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol (2004) 2.15
Retained lens fragments after cataract surgery: outcomes of same-day versus later pars plana vitrectomy. Am J Ophthalmol (2013) 2.13
Pars plana vitrectomy compared with pars plana vitrectomy combined with scleral buckle in the primary management of noncomplex rhegmatogenous retinal detachment. Retina (2014) 2.13
The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography. Retina (2011) 2.12
Multimodal imaging findings in retinal deep capillary ischemia. Retina (2014) 2.11
Pars plana vitrectomy for vitreous floaters: is there such a thing as minimally invasive vitreoretinal surgery? Retina (2014) 2.11
The expanded spectrum of focal choroidal excavation. Arch Ophthalmol (2011) 2.11
Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina (2007) 2.09
Differences in visual function and optic nerve structure between healthy eyes of blacks and whites. Arch Ophthalmol (2005) 2.09
Photoreceptor outer segment abnormalities as a cause of blind spot enlargement in acute zonal occult outer retinopathy-complex diseases. Am J Ophthalmol (2008) 2.08
Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials. Arch Ophthalmol (2009) 2.06
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study. Arch Ophthalmol (2006) 2.04
Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology (2010) 2.02
Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration. Retina (2014) 2.02
SMARTPHONE-BASED DILATED FUNDUS PHOTOGRAPHY AND NEAR VISUAL ACUITY TESTING AS INEXPENSIVE SCREENING TOOLS TO DETECT REFERRAL WARRANTED DIABETIC EYE DISEASE. Retina (2016) 2.01
Atypical presentations of ocular toxoplasmosis. Curr Opin Ophthalmol (2002) 1.99
Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Arch Ophthalmol (2005) 1.98
Enhanced depth imaging optical coherence tomography of deep optic nerve complex structures in glaucoma. Ophthalmology (2011) 1.98
Visual and anatomical outcomes of macular epiretinal membrane peeling after previous rhegmatogenous retinal detachment repair. Retina (2015) 1.98
The "pitchfork sign" a distinctive optical coherence tomography finding in inflammatory choroidal neovascularization. Retina (2013) 1.98
Transvitreal fibrinoid pseudoendophthalmitis after diabetic vitrectomy. Retina (2013) 1.97
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3. Ophthalmology (2003) 1.96
Spectral-domain optical coherence tomography: a comparison of modern high-resolution retinal imaging systems. Am J Ophthalmol (2010) 1.94
Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis. Retina (2005) 1.94
Vitelliform macular dystrophy. Ophthalmology (2006) 1.93
Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol (2011) 1.92
Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography. Am J Ophthalmol (2008) 1.92
Pathogenesis of macular holes and therapeutic implications. Am J Ophthalmol (2004) 1.91
Endophthalmitis caused by Streptococcus pneumoniae. Am J Ophthalmol (2004) 1.91
African Descent and Glaucoma Evaluation Study (ADAGES): III. Ancestry differences in visual function in healthy eyes. Arch Ophthalmol (2010) 1.89
Initial arcuate defects within the central 10 degrees in glaucoma. Invest Ophthalmol Vis Sci (2011) 1.89
Short-term outcomes of 23-gauge pars plana vitrectomy. Am J Ophthalmol (2008) 1.89
Infectious endophthalmitis after intravitreal injection of antiangiogenic agents. Retina (2009) 1.88
Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapy. Retina (2009) 1.87
Fundus autofluorescence in patients with pseudoxanthoma elasticum. Ophthalmology (2006) 1.87
Retinal thickness analysis by race, gender, and age using Stratus OCT. Am J Ophthalmol (2009) 1.86
Retinal ganglion cell count estimates associated with early development of visual field defects in glaucoma. Ophthalmology (2012) 1.86